PALLEIKO BENJAMIN L (CFO and Secretary) sold 2.2% of their position (10.93K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $292.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2026ACC: 0001366244-26-000010
Officer· CFO and Secretary
Since Sep 2018
-10.93K
Net shares
Net seller
$292.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
23.25K acquired · 34.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.25K
Price / share
—
Trade value
—
% of position
5.0%
5/21/2026
467.67K→490.92K
Common Stock
Direct
Shares
−10.93K
Price / share
$26.78
Trade value
$292.65K
% of position
2.2%
5/22/2026
490.92K→479.99K
Total
Net shares
+12.32K
Net value
-$292.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | M · Option Exercise | +23.25K | — | — | 5.0% | 467.67K | 490.92K |
| Common Stock Direct | 5/22/2026 | S · Sale | −10.93K | $26.78 | $292.65K | 2.2% | 490.92K | 479.99K |
| Total | +12.32K | -$292.65K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
23.25K shares
Shares
−23.25K
Strike price
Held after
255.75K
Exercisable
—
5/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock23.25K shares | 5/21/2026 | M · Option Exercise | −23.25K | — | 255.75K |